Shanghai Shyndec Pharmaceutical Co Ltd (600420) — Capital Reinvestment Ratio
Shanghai Shyndec Pharmaceutical Co Ltd (600420) has a Capital Reinvestment Ratio of 0.14x as of September 2025, meaning it reinvests 0% of its operating cash flow (CN¥486.04 Million) in capital expenditures (CN¥67.11 Million). Check tangible net worth ratio of Shanghai Shyndec Pharmaceutical Co Ltd to evaluate the tangible quality of the company's equity base.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Shanghai Shyndec Pharmaceutical Co Ltd Capital Reinvestment Ratio (2004–2025)
This chart tracks Shanghai Shyndec Pharmaceutical Co Ltd's Capital Reinvestment Ratio across 22 annual periods. For the full cash flow conversion analysis, see 600420 operating cash flow.
Annual Capital Reinvestment Ratio for Shanghai Shyndec Pharmaceutical Co Ltd (2004–2025)
Year-by-year Capital Reinvestment Ratio for Shanghai Shyndec Pharmaceutical Co Ltd from 2004 to 2025. See 600420 cash flow after capex ratio to measure how efficiently the company converts operating cash flow to free cash.
| Year | Reinvestment Ratio | Operating CF (CNY) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.16x | CN¥1.70 Billion | CN¥263.83 Million | ▲ +59.5% |
| 2024 | 0.10x | CN¥2.26 Billion | CN¥219.77 Million | ▼ -53.1% |
| 2023 | 0.21x | CN¥1.72 Billion | CN¥357.19 Million | ▲ +92.9% |
| 2022 | 0.11x | CN¥2.86 Billion | CN¥307.44 Million | ▼ -65.3% |
| 2021 | 0.31x | CN¥1.68 Billion | CN¥521.44 Million | ▲ +28.1% |
| 2020 | 0.24x | CN¥1.56 Billion | CN¥377.98 Million | ▼ -23.8% |
| 2019 | 0.32x | CN¥1.27 Billion | CN¥403.82 Million | ▲ +32.9% |
| 2018 | 0.24x | CN¥1.67 Billion | CN¥399.40 Million | ▲ +228.8% |
| 2017 | 0.07x | CN¥2.31 Billion | CN¥168.44 Million | ▼ -74.7% |
| 2016 | 0.29x | CN¥838.58 Million | CN¥241.30 Million | ▼ -72.2% |
| 2015 | 1.03x | CN¥226.65 Million | CN¥234.52 Million | ▼ -37.9% |
| 2014 | 1.67x | CN¥258.51 Million | CN¥430.53 Million | ▼ -32.6% |
| 2013 | 2.47x | CN¥207.50 Million | CN¥512.62 Million | ▲ +17.8% |
| 2012 | 2.10x | CN¥193.41 Million | CN¥405.52 Million | ▲ +122.3% |
| 2011 | 0.94x | CN¥136.12 Million | CN¥128.40 Million | ▼ -30.4% |
| 2010 | 1.36x | CN¥115.11 Million | CN¥156.02 Million | ▲ +322.0% |
| 2009 | 0.32x | CN¥97.43 Million | CN¥31.29 Million | ▲ +37.5% |
| 2008 | 0.23x | CN¥58.04 Million | CN¥13.56 Million | ▼ -44.2% |
| 2007 | 0.42x | CN¥82.31 Million | CN¥34.45 Million | ▼ -50.3% |
| 2006 | 0.84x | CN¥73.60 Million | CN¥62.00 Million | ▼ -31.9% |
| 2005 | 1.24x | CN¥57.90 Million | CN¥71.65 Million | ▲ +33.4% |
| 2004 | 0.93x | CN¥17.02 Million | CN¥15.79 Million | — |